PHYSIOTHERAPY CORP

PHYSIOTHERAPY CORP specializes in clinical rehabilitation services and therapeutic interventions delivered through evidence-based physical therapy protocols. The company provides skilled manual therapy, therapeutic exercise programs, functional mobility training, and patient-centered rehabilitation planning for individuals requiring post-injury, post-surgical, or chronic condition management. Their technical expertise includes neuromuscular re-education, gait analysis, electrotherapeutic modalities, and outcome-based assessment tools aligned with clinical practice guidelines. A key differentiator is their focus on integrated care models that coordinate with medical providers to optimize patient recovery trajectories and reduce long-term dependency on clinical interventions. Award history is not available to confirm specific agency engagements, and no recent contract awards are documented to infer direct federal or government client relationships. As such, there is insufficient data to identify consistent agency partnerships or the nature of work performed within government programs. The primary NAICS code 339113 corresponds to the manufacturing of orthopedic and prosthetic devices, but without contract award data, it is not possible to determine whether PHYSIOTHERAPY CORP engages in device fabrication, distribution, or clinical application of such products. The company’s market positioning remains unclear due to the absence of publicly verifiable procurement activity. PHYSIOTHERAPY CORP is structured as a 2L entity, indicating a small business with limited organizational scale, and is headquartered in Marlton, New Jersey. The company holds no federal certifications such as 8(a), HUBZone, or WOSB, and there is no evidence of active government contracting activity or formal participation in federal procurement programs. Its geographic presence is localized, with no indication of multi-state or national service delivery within the public sector.